NASDAQ:BCRX

Biocryst Pharmaceuticals Stock Predictions

etoro logo Buy BCRX
*Your capital is at risk
$8.25
-0.0900 (-1.08%)
At Close: Jun 03, 2026
Currently predicting for Fri, 5 Jun 2026

BCRX Prediction Chart

BCRX Predictions History

Latest community submissions for BCRX.
Predictor Target Session Target Price Result Direction Accuracy Score
Mar 12, 2026 $8.62 +1.53% $8.38 X 97.13% 0
Mar 12, 2026 $8.57 +0.96% $8.38 X 97.72% 0
Mar 12, 2026 Bearish $8.38 V 1
Feb 2, 2026 $6.70 +1.98% $6.62 V 98.77% 2
Feb 2, 2026 $6.65 +1.24% $6.62 V 99.51% 5
Feb 2, 2026 Bullish $6.62 V 1
Jan 21, 2026 $6.82 +2.19% $6.72 V 98.57% 2
Jan 21, 2026 $6.76 +1.37% $6.72 V 99.39% 4
Jan 21, 2026 Bullish $6.72 V 1
Jan 20, 2026 $6.81 +2.26% $6.67 V 97.89% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for BCRX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT BIOCRYST PHARMACEUTICALS
BioCryst Pharmaceuticals
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase II...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE